Pavel Aprelev is a scientist-turned-life-science executive with 10 years of experience advancing translational nanomedicine and cell therapy programs from bench to IND-enabling development. As Director of Corporate Development and a start-up member at Verismo Therapeutics, he oversees preclinical and clinical R&D and manufacturing for KIR-CAR T-cell products targeting solid tumors. His background combines a PhD in Materials Science with postdoctoral work at Penn focused on targeted drug delivery to pulmonary and hepatic endothelium, giving him uncommon strength in both materials characterization and biologics translation. Known as an agile learner and practical problem solver, he excels at integrating cross-functional teams in fast-paced, regulatory-driven environments. He brings hands-on experimental skills—from optical tweezers and powermeter prototypes to MATLAB modeling—alongside strategic program leadership. Based in Philadelphia, he pairs academic rigor with startup grit to de-risk complex therapeutic programs.
9 years of coding experience
7 years of employment as a software developer
Doctor of Philosophy - PhD Materials Science and Engineering, Doctor of Philosophy - PhD Materials Science and Engineering at Clemson University
Postdoctoral Fellowship Translational Nanomedicine and Drug Delivery , Postdoctoral Fellowship Translational Nanomedicine and Drug Delivery at University of Pennsylvania School of Medicine
Bachelor of Science (BS) Major: Physics. Minor: Mathematics Economics., Bachelor of Science (BS) Major: Physics. Minor: Mathematics Economics. at Union College
Contributions:11 pushes, 1 branch in 2 years 7 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Pavel Aprelev - Director Of Corporate Development Start-Up Member